(2,2-dimethyl-1,3-dioxolan-4-yl)methyl methacrylate

Eye irritation

Administrative data

Endpoint:

eye irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2017

Report date:

2017

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Test material

Test material information

Constituent 1

Reference substance name:

(2,2-dimethyl-1,3-dioxolan-4-yl)methyl methacrylate

EC Number:

230-408-6

EC Name:

(2,2-dimethyl-1,3-dioxolan-4-yl)methyl methacrylate

Cas Number:

7098-80-8

Molecular formula:

C10H16O4

IUPAC Name:

(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 2-methylprop-2-enoate

Test material form:

liquid

Test animals / tissue source

Details on test animals or tissues and environmental conditions:

EpiOcular
The EpiOcularTM model (OCL-200) is a three-dimensional non-keratinized tissue construct composed of normal human derived epidermal keratinocytes used to model the human corneal epithelium (compare Figure 1). The EpiOcularTM tissues (surface 0.6 cm²) are cultured on cell culture inserts (MILLICELLs®, 10 mm ø) and are commercially available as kits (EpiOcular™ 200), containing 24 tissues on shipping agarose.
Tissue model: OCL-200
Tissue Lot Number: 23718 (Certificates of Analysis see appendix)
Supplier: MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia

Test system

Vehicle:

unchanged (no vehicle)

Controls:

yes

Details on study design:

EpiOcular:
To assess the ability of the test material to directly reduce MTT a pretest (experimental conduct in accordance with GLP but without a GLP status) was performed. The test substance was added to 0.9 mL of the MTT solution. The mixture was incubated in the dark at about 37 °C for 3 hours. A negative control (de-ionized water) was tested concurrently. If the MTT solution color or, in case of water-insoluble test substances the border to the water-phase, turned blue / purple, the test substance was presumed to directly reduce MTT. The direct reduction of MTT by a test substance interferes with the color density produced by metabolic capacity of the tissue and would falsify the test results. In case where direct MTT reduction occurred, two freeze-killed control tissues each were treated with the test article and the negative control, in the same way as described in the following section.
Several test substances were tested in parallel within the present test (test no. 77) using the same control tissues (NC and PC). Two tissues were treated with each, the test substance, the PC and the NC. There are two separate protocols for liquids and solids, differing in exposure time and postincubation period. Due to the physical state of the test substance the protocol for liquids was applied. On the day of arrival in the laboratory, the tissues were transferred to sterile 6-well plates with 1 mL assay medium and preconditioned in the incubator at 37°C. After 1 hour the preincubation medium was replaced with fresh medium and preconditioning continued in the incubator at standard culture conditions for 16 – 24 hours. After the pre-incubation, the tissues were pre-treated with 20 µL of PBS in order to wet the tissue surface. The tissues were incubated at standard culture conditions for 30 minutes. Using a pipette, fifty microliter (50 µL) of the undiluted liquid test substance was applied covering the whole tissue surface. Control tissues were concurrently applied with 50 µL of sterile de-ionized water (NC) or with 50 µL of methyl acetate (PC). After application, the tissues were placed into the incubator until the total exposure time of 30 minutes was completed. To remove the test substance, the tissues were washed with sterile PBS. For this purpose the tissues were immersed and swiveled three times in each of three beakers filled with PBS. Washed tissues were immediately immersed into 12-well plates, pre-filled with 5 mL/well prewarmed medium (post-soak immersion) in order to remove residual test substance. After 12 minutes of post-soak immersion, each tissue was dried on absorbent paper and transferred to fresh 6-well plates filled with 1 mL/well pre-warmed medium. Subsequently, the tissues were incubated at standard culture conditions for 2 hours (postincubation period). After the post-incubation period, the assay medium was replaced by 0.3 mL MTT solution and the tissues were incubated in the incubator for 3 hours. After incubation, the tissues were washed with PBS to stop the MTT-incubation. The formazan that was metabolically produced by the tissues was extracted by incubation of the tissues in isopropanol at room temperature overnight or for at least 2 hours on a plate shaker. The optical density at a wavelength of 570 nm (OD570) of the extracts was determined spectrophotometrically. Blank values were established of 4 microtiter wells filled with isopropanol for each microtiter plate.

Negative control (NC): De-ionized water, sterile
Positive control (PC): Neat methyl acetate (CAS No.: 79-20-9)

Results and discussion

In vitro

Results

Remarks on result:

other: EpiOcular: Mean viability of the test-substance treated tissues was 49.9%.

Any other information on results incl. tables

The following results were obtained in the EpiOcular™ eye irritation assay:

The test substance is not able to reduce MTT directly.

The mean viability of the test-substance treated tissues was 49.9%.

Test substance		tissue 1	tissue 2	mean	inter-tissue variability [%]
NC	mean OD570	1.838	1.909	1.873
	viability [% of NC]	98.1	101.9	100.0	3.8
16/0065-1	mean OD570	0.926	0.944	0.935
	viability [% of NC]	49.4	50.4	49.9	1.0
PC	mean OD570	0.541	0.582	0.562
	viability [% of NC]	28.9	31.1	30.0	2.2

Summary of the individual test results of the in vitro eye irritation turnkey testing strategy:

Test Method	Test Result	Test Evaluation	Evaluation Test Strategy
BCOP Test	The mean IVIS of the test-substance treated corneas was 0.0	Not identified as corrosive or severe irritant	Ocular irritant
EpiOcular	Mean viability of the test-substance treated tissues was 49.9%	Irritant

 

Applicant's summary and conclusion

Interpretation of results:

Category 2 (irritating to eyes) based on GHS criteria

Conclusions:

Based on the results for EpiOcular Test and applying the evaluation criteria, Isopropylidenglycerolmethacrylate (IPGMA) shows an eye irritation potential in the in vitro eye irritation test under the test conditions chosen.